Inositol tetrakisphosphate limits NK cell effector functions by controlling PI3K signaling

Karsten Sauer1, Eugene Park, Sabine Siegemund

  • 1Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA. ksauer@scripps.edu

Blood
|November 24, 2012
PubMed

Insights

Inositol (1,3,4,5)tetrakisphosphate (IP(4)) drives natural killer (NK) cell maturation but limits their cancer-killing functions. This discovery reveals IP(4) as a key regulator of NK cell responses and potential therapeutic target.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Signaling

Background:

  • Natural killer (NK) cells are crucial for immune surveillance against tumors and infections.
  • NK cell effector functions are regulated by complex molecular pathways, including those involving PI3K and PLCγ.
  • Understanding NK cell development and function is vital for improving NK cell-based cancer therapies.

Purpose of the Study:

  • To investigate the role of inositol (1,3,4,5)tetrakisphosphate (IP(4)), a metabolite of IP(3), in NK cells.
  • To elucidate the impact of IP(4) on NK cell differentiation, receptor repertoire, and effector functions.

Main Methods:

  • Analysis of IP(4) function in NK cell development and maturation.
  • Investigation of IP(4)'s effect on NK cell receptor repertoire.
  • Assessment of IP(4)'s influence on NKR-induced IFNγ secretion, granule exocytosis, and target cell killing.
  • Exploration of IP(4)'s mechanism of action, including its interaction with the Akt pathway.

Main Results:

  • IP(4) promotes the terminal differentiation of NK cells and the acquisition of a mature NK cell receptor (NKR) repertoire.
  • In mature NK cells, IP(4) inhibits NKR-induced IFNγ secretion, granule exocytosis, and target cell cytotoxicity.
  • IP(4) exerts its inhibitory effects, in part, by inhibiting the PIP(3) effector-kinase Akt.

Conclusions:

  • IP(4) is a novel and important regulator of both NK cell development and function.
  • The findings expand the understanding of molecular mechanisms that dampen NK cell responses.
  • Regulation of PI3K signaling by soluble IP(4) represents a broadly significant signaling paradigm.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...